Navigation Links
Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
Date:6/4/2009

Lifeclinic will be featuring the LC500 Health Station in support of the Novartis and IAFF STOP•DROP•CONTROL high blood pressure awareness and community health outreach campaign at the IAFF 10th Biennial Dominick F. Barbera EMS Conference.

Burtonsville, MD (PRWEB) June 4, 2009 -- Lifeclinic International, Inc., the world's leading manufacturer and distributor of automated blood pressure monitors and health testing stations, will exhibit its LC500 Health Station with Novartis Pharmaceuticals Corporation at the International Association of Fire Fighters (IAFF) 10th Biennial Dominick F. Barbera EMS Conference. The Conference will be held at the Fontainebleau Miami Beach Hotel in Miami, Florida, June 7 - 10. Lifeclinic will be located at Novartis booth #8.

Lifeclinic will be featuring the LC500 Health Station in support of the Novartis and IAFF STOP•DROP•CONTROL high blood pressure awareness and community health outreach campaign. To date, the program has provided hundreds of IAFF affiliates with the materials and resources to conduct blood pressure screening and educational activities for IAFF members and their communities.

"Lifeclinic is pleased to be supporting Novartis and the IAFF in this campaign," said Steve Halperin, Lifeclinic's Chief Marketing Officer. Halperin added, "For years, firehouses across the nation have acted as a base of outreach; in many communities their doors are open for those who want to have their blood pressure measured. We see our health stations as a valuable asset and tool for IAFF members in meeting the ever increasing technological demands required in today's biometric testing
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

0

GOOD

Page: 1 2 3

Related medicine news :

1. CBS Outernet Partners With Lifeclinic International to Bring Interactive Health Programming and Advertising to Pharmacy Locations Nationwide
2. CBS Outernet and Lifeclinic To Show Wellness Channel at NACDS Marketplace
3. Lifeclinic to Feature Latest Health Stations at McKesson's Pharmacy of the Future
4. Lifeclinic International Has Named John T. Kelly, M.D., Ph.D. Chief Medical Officer
5. Lifeclinic Names Harvard Ph.D. as New Chief Medical Officer
6. Lifeclinic International Lead Sponsor at Harvard Business School Health Conference
7. Lifeclinic International and Get Real Consulting Team-Up to Launch Microsoft's HealthVault
8. Benefits of a Lifeclinic LC300 Automated Blood Pressure Monitor Recently Featured on Daytime Medical Talk Show
9. Lifeclinic International Achieves ISO 13485:2003
10. Study Finds Lifeclinic Self-Testing Health Stations in Workplace Help Reduce Hypertension and Obesity
11. Lifeclinic International to Acquire Controlling Interest in My Health Rewards
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
Lifeclinic Supports the Novartis and International Association of Fire Fighters Campaign Against Hypertension
Breaking Medicine News(10 mins):Health News:U.S. Cancer Cases, Deaths Continue to Drop 2Health News:U.S. Cancer Cases, Deaths Continue to Drop 3Health News:U.S. Cancer Cases, Deaths Continue to Drop 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 2Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 3Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 4Health News:Roche Announces Shipments of New Supplies of Children's Tamiflu in the U.S. 5Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3Health News:Genetic variations indicate risk of recurrence, secondary cancer among head and neck cancer patients 2Health News:Anthem Blue Cross and Blue Shield in Maine and National Council on Aging Provide Vital Benefits Information to Economically Challenged Older Adults 2
Breaking Medicine Technology:Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 2Despite Limited Capital Equipment Purchases In 2009, The Global Powered Surgical Instrument Market Held Its Value At $800 Million 3Hill-Rom Announces Appointment of James R. Giertz to Board of Directors 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 2Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 3Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 4Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 5Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 6Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data, Including New Survival Data, on KRX-0401 (Perifosine) in the Treatment of Advanced Multiple Myeloma at the 51st Annual Meeting of the American Society of Hematology 7EntreMed Reports Second Quarter 2009 Financial Results 53818 1EntreMed Reports Second Quarter 2009 Financial Results 53818 2EntreMed Reports Second Quarter 2009 Financial Results 53818 3EntreMed Reports Second Quarter 2009 Financial Results 53818 4SXC Health solutions announces record second quarter financial results 53815 1SXC Health solutions announces record second quarter financial results 53815 2SXC Health solutions announces record second quarter financial results 53815 3SXC Health solutions announces record second quarter financial results 53815 4SXC Health solutions announces record second quarter financial results 53815 5SXC Health solutions announces record second quarter financial results 53815 6SXC Health solutions announces record second quarter financial results 53815 7SXC Health solutions announces record second quarter financial results 53815 8SXC Health solutions announces record second quarter financial results 53815 9SXC Health solutions announces record second quarter financial results 53815 10SXC Health solutions announces record second quarter financial results 53815 11SXC Health solutions announces record second quarter financial results 53815 12SXC Health solutions announces record second quarter financial results 53815 13SXC Health solutions announces record second quarter financial results 53815 14SXC Health solutions announces record second quarter financial results 53815 15SXC Health solutions announces record second quarter financial results 53815 16SXC Health solutions announces record second quarter financial results 53815 17SXC Health solutions announces record second quarter financial results 53815 18SXC Health solutions announces record second quarter financial results 53815 19Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 1Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 2Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 3Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 4Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 5Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 6Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 7Stereotaxis Reports 19 25 Second Quarter Revenue Growth 53810 8